Filtered By:
Drug: Abciximab
Procedure: Coronary Angioplasty

This page shows you your search results in order of date.

Order by Relevance | Date

Total 17 results found since Jan 2013.

Association between the number of academic research consortium for high bleeding risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of academic research consortium for high bleeding risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of academic research consortium for high bleeding risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of academic research consortium for high bleeding risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention.
The objectives were to assess the efficacy and safety of abciximab versus tirofiban in patients with ST-elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) and pretreated with ticagrelor, and to identify independent predictor factors of efficacy, bleeding and platelet drop. Three hundred sixty-two patients were divided by GPI administered. Clinical, laboratory, angiographic and outcome characteristics were compared. The primary objective was a composite efficacy endpoint (death from any cause, nonfatal myocardial infarction and nonfatal stroke) at 30 days. The seconda...
Source: Platelets - February 10, 2021 Category: Hematology Tags: Platelets Source Type: research

Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysis
ConclusionsRoutine GPI administration in STEMI resulted in a reduction in mortality, driven by reductions in recurrent ischemic events—however predominantly in pre-prasugrel/ticagrelor trials. Trials with contemporary STEMI management are needed to confirm these findings.RésuméContexteLes lignes directrices recommandent le traitement d’appoint par des inhibiteurs des glycoprotéines IIb-IIIa (IGP) uniquement chez certains patients ayant subi un infarctus du myocarde avec élévation du segment ST (STEMI) aigu. Cette étude visait à évaluer l’utilisation systématique des IGP chez les patients ayant subi un STEMI ...
Source: Canadian Journal of Cardiology - November 2, 2019 Category: Cardiology Source Type: research

Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention.
CONCLUSIONS: IC versus IV abciximab did not enhance myocardial reperfusion in non-selected patients with STEMI undergoing primary PCI after aspiration thrombectomy had successfully been performed. PMID: 30460974 [PubMed - as supplied by publisher]
Source: Cardiovascular Journal of Africa - November 20, 2018 Category: Cardiology Authors: Bedjaoui A, Allal K, Lounes MS, Belhadi CE, Mekarnia A, Sediki S, Kara M, Azaza A, Monsuez JJ, Benkhedda S Tags: Cardiovasc J Afr Source Type: research

Risk Scoring System to Assess Outcomes in Patients Treated with Contemporary Guideline-Adherent Optimal Therapies after Acute Myocardial Infarction.
CONCLUSIONS: The KorMI system would be a useful tool for predicting outcomes in survivors treated with guideline-adherent optimal therapies after AMI. PMID: 29856143 [PubMed]
Source: Korean Circulation Journal - June 3, 2018 Category: Cardiology Tags: Korean Circ J Source Type: research

Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program Original Articles
Conclusions— In this national cohort, 18% of patients undergoing PCI had contraindications to common antiplatelet medications. Approximately 6% of those patients received a contraindicated medication with attendant bleeding risk, although this did not translate into significantly higher risk of 30-day mortality. Continued efforts to reduce contraindicated medication use may help avoid periprocedural complications.
Source: Circulation: Cardiovascular Quality and Outcomes - July 18, 2016 Category: Cardiology Authors: Barnes, G. D., Stanislawski, M. A., Liu, W., Baron, A. E., Armstrong, E. J., Ho, P. M., Klein, A., Maddox, T. M., Nallamothu, B. K., Rumsfeld, J. S., Tsai, T. T., Bradley, S. M. Tags: Platelets, Anticoagulants, Percutaneous Coronary Intervention, Stent, Quality and Outcomes Original Articles Source Type: research